Recently, we found mifepristone (MIF), a synthetic progesterone receptor (PR) antagonist, which has been widely used as an abortifacient and emergency contraceptive for decades 21, suppresses TNBC cell proliferation and tumor growth partially through inhibiting KLF5 expression via inducing miR-153 13. This evidence concerns the gene KLF5 and neoplasm.